Manno‐oligosaccharides from Cassia Seed Gum Attenuate Atherosclerosis through Inflammation Modulation and Intestinal Barrier Integrity Improvement in ApoE−/− Mice

Abstract

ScopeManno‐oligosaccharides from cassia seed gum (CMOS) have demonstrated anti‐inflammatory and regulatory effects on cholesterol metabolism. However, their protective effects against the progression of atherosclerosis (AS) and underlying molecular mechanisms have not been investigated. This study investigates the anti‐atherosclerotic effects of CMOS on ApoE−/− mice.Methods and resultsCMOS are supplemented in atherosclerotic male ApoE−/− mice fed with a high‐fat‐high‐cholesterol diet (HFHCD). After the 12‐week intervention, CMOS at 1200 mg kg−1·bw d−1 significantly decrease the atherosclerotic lesion area by 0.63‐fold and the aortic arch lesion size by 0.63‐fold when compared to the HFHCD group. Moreover, inflammation in atherosclerotic lesions is reduced by CMOS intervention, and the levels of serum lipids and inflammatory cytokines are decreased. The number of goblet cells and the expression of intestinal epithelial tight junction proteins in the H‐CMOS group increase, thus indicating that CMOS can restore intestinal barrier integrity in atherosclerotic mice. Furthermore, CMOS reshape the unbalanced gut microbiota in ApoE−/− mice caused by HFHCD, and reduce the relative abundance of Desulfovibrio and Faecalibaculum that exhibits positive relationships with inflammation.ConclusionCMOS inhibit inflammation, alter intestinal barrier integrity, and regulate gut microbiota to attenuate AS in ApoE−/− mice.